Back to LLY
FIDEURAM - INTESA SANPAOLO PRIVATE BANKING S.P.A. → LLY
FIDEURAM - INTESA SANPAOLO PRIVATE BANKING S.P.A. LLY Position History
Eli Lilly and Company • Healthcare
Quarters held
5
Latest value
$39.5M
Q3 2026
Peak value
$45M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $36M |
| Q4 2025 | $36M |
| Q1 2026 | $32.6M |
| Q2 2026 | $45M |
| Q3 2026 | $39.5M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $39.5M | 34.2K | — | — |
| Q2 2026 | $45M | 37.5K | — | — |
| Q1 2026 | $32.6M | 35.5K | — | — |
| Q4 2025 | $36M | 33.5K | — | — |
| Q4 2025 | $36M | 33.5K | — | — |
Other funds holding LLY
$108.4B
$104.2B
$99.1B
$84.5B
$79.5B
$72.9B
$62.3B
$59.7B